泰利必妥

tài lì bì tuǒ
  • Tarivid
泰利必妥泰利必妥
  1. 目的测定并比较泰利必妥滴眼液、环丙沙星滴眼液、庆大霉素滴眼液用于预防新生儿眼炎的体外抗菌活性。

    Objective To evaluate in vitro antibacterial activities of ofloxacin , ciprofloxacin and gentamycin for preventing ophthalmia neonatorum prophylaxis .

  2. 重组人表皮生长因子与泰利必妥滴耳液联合治疗外伤性鼓膜穿孔的疗效观察

    The healing effect of combining recombinant human epidermal growth factor and ofloxacin ear drops on the traumatic tympanic membrane perforations

  3. 本文报告用泰利必妥治疗呼吸道感染性疾病80例,有效率90.0%,细菌转阴率93.2%。

    Tarivid was used for the treatment of infectious disease of respiratory tract in 80 patients . The total effective rate was 90.0 % . The bacterial clearance rate was 93.2 % .

  4. 104耳鼓膜穿孔耳内窥镜电脑成像系统分析重组人表皮生长因子与泰利必妥滴耳液联合治疗外伤性鼓膜穿孔的疗效观察

    The effect of Oto-endoscope Computer Imaging System on the evaluation of the tympanic membrane perforation ; The healing effect of combining recombinant human epidermal growth factor and ofloxacin ear drops on the traumatic tympanic membrane perforations

  5. 实验组20例(22眼),术后使用泰利必妥滴眼液4次/日、0.1%氟美瞳滴眼液6次/日及0.1%玻璃酸钠3次/日点眼,用药1周。

    In the experimental group ( 20 patients , 22 eyes ), the patients were given Ofloxacin ( qid ), 0.1 % Fluorometholone ( q2h ) and 0.1 % HA ( tid ) eyedrops for 1 week .